Live Breaking News & Updates on Tim Demuth

Stay updated with breaking news from Tim demuth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference

EQS-News: MorphoSys AG

/ Key word: Conference

MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference

08.01.2024 / 08:00 CET/CEST

The issuer is. ....

United States , San Francisco , Julia Neugebauer , Jean Paul Kress , Thomas Biegi , Tim Demuth , Lucinda Crabtree , Eamonn Nolan , Corporate Affairs , Corporate Communications Investor Relations , Chief Executive Officer , Healthcare Conference , Chief Financial Officer , Chief Research , Development Officer , Vice President , Global Investor , Corporate Communications ,

MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study

MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , United Kingdom , City Of , Raajitk Rampal , Tim Demuth , Julia Neugebauer , Ruben Mesa , Eamonn Nolan , Claire Harrison , Thomas Biegi , European Medicines Agency , Constellation Pharmaceuticals Inc , Hilton San Diego Bayfront Hotel , Lymphoma Society , Myeloproliferative Neoplasms Program , Development Officer , Atrium Health Levine Cancer Center , American Society Of Hematology , Drug Administration , Dynamic International Prognostic Scoring System , Exchange Commission , Memorial Sloan Kettering Cancer Center , American Society , Annual Meeting , Hematologic Malignancies ,

EQS-News: MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study

EQS-News: MorphoSys AG / Key word(s): Conference MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in. ....

United States , City Of , United Kingdom , San Diego , Eamonn Nolan , Raajitk Rampal , Tim Demuth , Thomas Biegi , Julia Neugebauer , Ruben Mesa , Claire Harrison , Memorial Sloan Kettering Cancer Center , Drug Administration , European Medicines Agency , Exchange Commission , Hilton San Diego Bayfront Hotel , Myeloproliferative Neoplasms Program , Lymphoma Society , Atrium Health Levine Cancer Center , American Society Of Hematology , Constellation Pharmaceuticals Inc , Development Officer , American Society , Annual Meeting , Hematologic Malignancies , Memorial Sloan Kettering Cancer ,

Morphosys plans 2024 application for cancer drug - share price plunges after data

The drug researcher Morphosys has achieved a breakthrough in clinical trials with its promising drug pelabresib against the rare blood cancer myelofibrosis. In a pivotal study, the Bavarians hit their. ....

United States , Jean Paul Kress , Tim Demuth , Drug Administration , Constellation Pharmaceuticals , Paul Kress ,

MorphoSys fails secondary in blood cancer trial, sinking stock

MorphoSys fails secondary in blood cancer trial, sinking stock
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Tim Demuth , Jean Paul Kres , Morgan Stanley , Constellation Pharmaceuticals , Big Pharma ,